GLP-1 receptor agonists show promise in treating substance use disorders
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due ...
Tag: Agonist
AlphaFold accelerates discovery of potential antipsychotic drugs by outperforming traditional methods
In a recent study published in the journal Science Advances, researchers in Sweden conducted virtual screens of over 16 million ...
Semaglutide may reduce smoking risks for diabetes patients
In a recent study published in the journal Annals of Internal Medicine, a team of researchers from the National Institutes ...
Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity
In a recent study published in Scientific Reports, researchers evaluated the impact of semaglutide and tirzepatide medications on alcohol consumption ...
Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight
A study analyzing the PIONEER trial data claims that orally administered semaglutide is highly effective in reducing glycated hemoglobin (HbA1c) ...
Researchers present a new strategy for self-adjuvanting vaccine development
This new article publication from Acta Pharmaceutica Sinica B, discusses a fully synthetic Tn-based three-component cancer vaccine using covalently linked ...
Scientists identify papain-like protease inhibitor against COVID-19
In a recent study posted to the bioRxiv* preprint server, researchers identified a papain-like protease inhibitor for treating severe acute ...
Scientists explore SARS-CoV-2 spike protein and platelet-activating factor
In a recent study published in the IUBMB journal, researchers assessed the association between platelet-activating factor (PAF) and severe acute ...
POPULAR NEWS
